{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:49:31Z","timestamp":1794376171298,"version":"4.9.0"},"reference-count":103,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1979,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2893.2010.01307.x","type":"journal-article","created":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T07:05:17Z","timestamp":1270105517000},"page":"381-390","source":"Crossref","is-referenced-by-count":30,"title":["The complex interrelationships between chronic lung and liver disease: a review"],"prefix":"10.1111","volume":"17","author":[{"given":"P.","family":"Spagnolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zeuzem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Richeldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Du Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,1]]},"reference":[{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1056\/NEJMra0707185","article-title":"Hepatopulmonary syndrome - a liver-induced lung vascular disorder","volume":"358","author":"Rodriguez-Roisin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jhep.2006.07.002","article-title":"The hepatopulmonary syndrome","volume":"45","author":"Palma","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1183\/09031936.95.08111883","article-title":"Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome","volume":"8","author":"Cremona","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1164\/rccm.200201-027OC","article-title":"Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome","volume":"166","author":"Rabiller","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB5|cit5","first-page":"944","article-title":"Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome","volume":"277","author":"Zhang","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJM196602102740601","article-title":"Arterial changes in the lungs in cirrhosis of the liver - lung spider nevi","volume":"274","author":"Berthelot","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.21141","article-title":"Effects of nebulized NG-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome","volume":"43","author":"G\u00f3mez","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.04.00010904","article-title":"Pulmonary-hepatic vascular disorders (PHD)","volume":"24","author":"Rodr\u00edguez-Roisin","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0168-8278(99)80143-3","article-title":"Hepatopulmonary syndrome associated with cardiorespiratory disease","volume":"30","author":"Mart\u00ednez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.20358","article-title":"Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome","volume":"40","author":"G\u00f3mez","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1378\/chest.97.5.1165","article-title":"Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates: screening by two-dimensional contrast-enhanced echocardiography","volume":"97","author":"Krowka","year":"1990","journal-title":"Chest"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1164\/ajrccm.153.3.8630562","article-title":"Refractory hypoxemia during liver cirrhosis. Hepatopulmonary syndrome or \u201cprimary\u201d pulmonary hypertension?","volume":"153","author":"Raffy","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1378\/chest.118.3.615","article-title":"Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning","volume":"118","author":"Krowka","year":"2000","journal-title":"Chest"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/jlts.2002.35544","article-title":"Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome","volume":"8","author":"Collisson","year":"2002","journal-title":"Liver Transpl"},{"issue":"Suppl.","key":"10.1111\/j.1365-2893.2010.01307.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1002\/lt.20971","article-title":"Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome","volume":"12","author":"Fallon","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1378\/chest.104.2.515","article-title":"Hepatopulmonary syndrome: clinical observations and lack of therapeutic response to somatostatin analogue","volume":"104","author":"Krowka","year":"1993","journal-title":"Chest"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1183\/09031936.02.00068002","article-title":"Haemodynamic evaluation of pulmonary hypertension","volume":"20","author":"Chemla","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/gut.52.9.1355","article-title":"Portopulmonary hypertension in decompensated cirrhosis with refractory ascites","volume":"52","author":"Benjaminov","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB20|cit20","first-page":"849","article-title":"Pulmonary hypertension complicating portal hypertension","volume":"120","author":"Lebrec","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1183\/09031936.98.11051153","article-title":"Pulmonary vascular disorders in portal hypertension","volume":"11","author":"Herv\u00e9","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200809-1472OC","article-title":"Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease","volume":"179","author":"Roberts","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(04)16107-2","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome","volume":"363","author":"Hoeper","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2006-947294","article-title":"Evolving dilemmas and management of portopulmonary hypertension","volume":"26","author":"Krowka","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/lt.20016","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database","volume":"10","author":"Krowka","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1378\/chest.123.2.562","article-title":"Portopulmonary hypertension: a tale of two circulations","volume":"123","author":"Budhiraja","year":"2003","journal-title":"Chest"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(03)13808-1","article-title":"Primary biliary cirrhosis","volume":"362","author":"Talwalkar","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0002-9343(87)90664-4","article-title":"Sarcoidosis and primary biliary cirrhosis: literature review and illustrative case","volume":"83","author":"Keefe","year":"1987","journal-title":"Am J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00004836-198708000-00015","article-title":"Pulmonary involvement in primary biliary cirrhosis","volume":"9","author":"Wallace","year":"1987","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1378\/chest.90.6.842","article-title":"Primary biliary cirrhosis: subclinical inflammatory alveolitis in patients with normal chest roentgenograms","volume":"90","author":"Wallaert","year":"1986","journal-title":"Chest"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMct061675","article-title":"Peginterferon and ribavirin for chronic hepatitis C","volume":"355","author":"Hoofnagle","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM200012073432301","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C","volume":"343","author":"Zeuzem","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB36|cit36","volume-title":"Pharmaceuticals and Medical Devices Safety Information","year":"2008"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10620-009-0797-1","article-title":"Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature","volume":"55","author":"Slavenburg","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.124.1.406","article-title":"Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS","volume":"124","author":"Abi-Nassif","year":"2003","journal-title":"Chest"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.hrtlng.2007.10.002","article-title":"Adult respiratory distress syndrome after treatment with pegylated interferon alpha-2a and ribavirin","volume":"37","author":"Vartany","year":"2008","journal-title":"Heart Lung"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1378\/chest.128.4.2882","article-title":"Hepatitis C virus and the lung: implications for therapy","volume":"128","author":"Moorman","year":"2005","journal-title":"Chest"},{"issue":"Suppl. 5","key":"10.1111\/j.1365-2893.2010.01307.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/hep.22956","article-title":"Benefits and risks of interferon therapy for hepatitis B","volume":"49","author":"Perrillo","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.22403","article-title":"Albinterferon alfa-2b dosed every two or four weeks in interferon-na\u00efve patients with genotype 1 chronic hepatitis C","volume":"48","author":"Zeuzem","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cgh.2008.10.035","article-title":"Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C","volume":"7","author":"Nelson","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cgh.2008.02.056","article-title":"Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2\/3 chronic hepatitis C patients","volume":"6","author":"Bain","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0168-8278(98)80357-7","article-title":"Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C","volume":"28","author":"Hoffmann","year":"1998","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB46|cit46","first-page":"24","article-title":"Cells and cytokines involved in the pathogenesis of sarcoidosis","volume":"16","author":"Moller","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.md.0000157577.69729.e6","article-title":"Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases","volume":"84","author":"Ramos-Casals","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-2007-970333","article-title":"Pulmonary sarcoidosis","volume":"28","author":"Lynch","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","article-title":"Sarcoidosis","volume":"361","author":"Baughman","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2007-970335","article-title":"Extrapulmonary sarcoidosis","volume":"28","author":"Judson","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0025-6196(11)63733-6","article-title":"Sarcoidosis of the liver and bile ducts","volume":"73","author":"Ishak","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0002-9343(75)90396-4","article-title":"Chronic intrahepatic cholestasis of sarcoidosis","volume":"59","author":"Rudzki","year":"1975","journal-title":"Am J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB54|cit54","first-page":"73","article-title":"Course of asymptomatic liver involvement in sarcoidosis: the role of therapy in selected cases","volume":"14","author":"Vatti","year":"1997","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB55|cit55","first-page":"147","article-title":"Methotrexate for sarcoidosis","volume":"15","author":"Baughman","year":"1998","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF01318522","article-title":"Hepatic granulomatosis and sarcoidosis","volume":"29","author":"Israel","year":"1984","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00007890-199604150-00024","article-title":"Sarcoidosis recurrence following lung transplantation","volume":"61","author":"M\u00fcller","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/S0041-1345(97)00488-0","article-title":"Recurrent hepatic sarcoidosis following liver transplantation","volume":"29","author":"Fidler","year":"1997","journal-title":"Transplant Proc"},{"issue":"Suppl.","key":"10.1111\/j.1365-2893.2010.01307.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0168-8278(99)80381-X","article-title":"Hepatitis C virus infection in the United States","volume":"31","author":"Alter","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1378\/chest.123.2.596","article-title":"Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients","volume":"123","author":"Kanazawa","year":"2003","journal-title":"Chest"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-117-7-573","article-title":"Hepatitis C virus infection in patients with essential mixed cryoglobulinemia","volume":"117","author":"Misiani","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0168-8278(99)80239-6","article-title":"Extrahepatic manifestations of HCV infection: facts and controversies","volume":"31","author":"Zignego","year":"1999","journal-title":"J Hepatol"},{"issue":"Suppl.","key":"10.1111\/j.1365-2893.2010.01307.x-BIB65|cit65","first-page":"S33","article-title":"Hepatitis C virus as a lymphotropic agent: evidences and pathogenetic implications","volume":"13","author":"Zignego","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.3748\/wjg.14.5880","article-title":"Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis","volume":"14","author":"Arase","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/rheumatology\/36.3.360","article-title":"Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection","volume":"36","author":"Ferri","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1755-1536-1-2","article-title":"Viruses as co-factors for the initiation or exacerbation of lung fibrosis","volume":"1","author":"Vannella","year":"2008","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jmv.2108","article-title":"Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C","volume":"66","author":"Idilman","year":"2002","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/thx.51.3.312","article-title":"Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection","volume":"51","author":"Kubo","year":"1996","journal-title":"Thorax"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1683","article-title":"Idiopathic pulmonary fibrosis and hepatitis C virus infection","volume":"148","author":"Irving","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/ajrccm\/146.1.266","article-title":"Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus","volume":"146","author":"Ueda","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3748\/wjg.v10.i3.381","article-title":"Values of high-resolution computed tomography and pulmonary function tests in managements of patients with chronic hepatitis C virus infection","volume":"10","author":"Okutan","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00006231-200205000-00003","article-title":"Impaired lung epithelial permeability in hepatitis C virus antibody positive patients detected by 99mTc-DTPA aerosol scintigraphy","volume":"23","author":"Kula","year":"2002","journal-title":"Nucl Med Commun"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/ajrccm.155.1.9001319","article-title":"Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis","volume":"155","author":"Baumgartner","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0140-6736(96)90465-1","article-title":"Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis","volume":"347","author":"Hubbard","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0953-6205(02)00066-3","article-title":"Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis","volume":"13","author":"Teuber","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jhep.2003.10.009","article-title":"Extrahepatic disease manifestations of HCV infection: some current issues","volume":"40","author":"Agnello","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/01.smj.0000216469.04854.2a","article-title":"Epstein-Barr virus hepatitis: case series and review","volume":"99","author":"Crum","year":"2006","journal-title":"South Med J"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.3748\/wjg.14.4849","article-title":"Cytomegalovirus infection after liver transplantation: current concepts and challenges","volume":"14","author":"Razonable","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"Suppl. 3","key":"10.1111\/j.1365-2893.2010.01307.x-BIB82|cit82","first-page":"67","article-title":"Human cytomegalovirus DNA level in patients with idiopathic pulmonary fibrosis","volume":"55","author":"Dworniczak","year":"2004","journal-title":"J Physiol Pharmacol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JCM.41.6.2633-2640.2003","article-title":"Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis","volume":"41","author":"Tang","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1183\/09031936.97.10092040","article-title":"Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis","volume":"10","author":"Yonemaru","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(84)90702-5","article-title":"Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association?","volume":"2","author":"Vergnon","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1164\/ajrccm.159.4.9807077","article-title":"The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis","volume":"159","author":"Stewart","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/thx.52.10.888","article-title":"Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection","volume":"52","author":"Wangoo","year":"1997","journal-title":"Thorax"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB88|cit88","first-page":"123","article-title":"HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis","volume":"22","author":"Zam\u00f2","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1378\/chest.122.5.1818","article-title":"Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys","volume":"122","author":"De Serres","year":"2002","journal-title":"Chest"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1056\/NEJMcp0900449","article-title":"Clinical practice. Alpha1-antitrypsin deficiency","volume":"360","author":"Silverman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1183\/09031936.00096508","article-title":"Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights","volume":"34","author":"Gooptu","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.humpath.2004.08.013","article-title":"The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the national registry for individuals with Severe Deficiency of Alpha-1 Antitrypsin","volume":"35","author":"Tomashefski","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMra010772","article-title":"Alpha1-antitrypsin deficiency - a model for conformational diseases","volume":"346","author":"Carrell","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM197606102942404","article-title":"Liver disease in alpha 1-antitrypsin deficiency detected by screening of 200,000 infants","volume":"294","author":"Sveger","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3109\/00365528509088844","article-title":"Liver disease in alpha 1-antitrypsin deficiency: aspects of incidence and prognosis","volume":"20","author":"Eriksson","year":"1985","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0954-6820.1978.tb08452.x","article-title":"Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z","volume":"204","author":"Larsson","year":"1978","journal-title":"Acta Med Scand"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/ajrccm.158.1.9712017","article-title":"Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin","volume":"158","author":"Alpha-1-Antitrypsin Deficiency Registry Study Group","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"302","author":"Bartlett","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O\u2019Sullivan","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/318075","article-title":"Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis","volume":"183","author":"Burns","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB102|cit102","volume-title":"2006 Annual Data Report to the Center Directors","author":"Cystic Fibrosis Foundation Patient Registry","year":"2007"},{"key":"10.1111\/j.1365-2893.2010.01307.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MCP.0b013e3282f10a16","article-title":"Liver disease in cystic fibrosis","volume":"13","author":"Colombo","year":"2007","journal-title":"Curr Opin Pulm Med"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2010.01307.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2893.2010.01307.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T09:03:12Z","timestamp":1625562192000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2010.01307.x"}},"subtitle":["Liver and lung disease associations"],"short-title":[],"issued":{"date-parts":[[2010,4,1]]},"references-count":103,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2010.01307.x","relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,1]]}}}